90 related articles for article (PubMed ID: 19187271)
1. Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma.
Sgambato A; Camerini A; Genovese G; De Luca F; Viacava P; Migaldi M; Boninsegna A; Cecchi M; Sepich CA; Rossi G; Arena V; Cittadini A; Amoroso D
Cancer Sci; 2010 Sep; 101(9):2080-6. PubMed ID: 20626751
[TBL] [Abstract][Full Text] [Related]
2. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
Palacios F; Yan XJ; Ferrer G; Chen SS; Vergani S; Yang X; Gardner J; Barrientos JC; Rock P; Burack R; Kolitz JE; Allen SL; Kharas MG; Abdel-Wahab O; Rai KR; Chiorazzi N
Leukemia; 2021 Apr; 35(4):1037-1052. PubMed ID: 33504942
[TBL] [Abstract][Full Text] [Related]
3. Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells.
Secchiero P; Barbarotto E; Gonelli A; Tiribelli M; Zerbinati C; Celeghini C; Agostinelli C; Pileri SA; Zauli G
Am J Pathol; 2005 Dec; 167(6):1599-607. PubMed ID: 16314473
[TBL] [Abstract][Full Text] [Related]
4. Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates.
Mazzarello AN; Gugiatti E; Cossu V; Bertola N; Bagnara D; Carta S; Ravera S; Salvetti C; Ibatici A; Ghiotto F; Colombo M; Cutrona G; Marini C; Sambuceti G; Fais F; Bruno S
Cancer Immunol Immunother; 2024 Jan; 73(2):27. PubMed ID: 38280019
[TBL] [Abstract][Full Text] [Related]
5. p27(Kip1) and STMN1: partners again?
Atweh GF; Iancu-Rubin C
Cell Cycle; 2014; 13(20):3163. PubMed ID: 25485493
[No Abstract] [Full Text] [Related]
6. Lymphocytes from chronic lymphocytic leukaemia undergo ABL1-linked amoeboid motility and homotypic interaction as an early adaptive change to ex vivo culture.
Hutchinson CV; Natarajan S; Johnson SM; Adams JA; Rees-Unwin KS; Burthem J
Exp Hematol Oncol; 2014 Mar; 3(1):7. PubMed ID: 24618035
[TBL] [Abstract][Full Text] [Related]
7. Erythrophagocytosis by lymphocytes in chronic lymphocytic leukemia.
Wang S; Bo J
Int J Lab Hematol; 2024 Jun; 46(3):421-422. PubMed ID: 37855188
[No Abstract] [Full Text] [Related]
8. Stable improvement in classical B-cell chronic lymphocytic leukemia with dietary interventions: A personal experience.
Plooij FX; Raemaekers J
Clin Case Rep; 2020 Dec; 8(12):2948-2954. PubMed ID: 33363857
[TBL] [Abstract][Full Text] [Related]
9. Binucleated and cloverleaf-shaped nucleus in lymphocytes in CLL.
Barros Pinto MP; Cabeçadas J
Blood; 2024 Feb; 143(9):833. PubMed ID: 38421814
[No Abstract] [Full Text] [Related]
10. CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia.
Ciszak L; Frydecka I; Wolowiec D; Szteblich A; Kosmaczewska A
Clin Exp Med; 2016 Aug; 16(3):317-32. PubMed ID: 26003188
[TBL] [Abstract][Full Text] [Related]
11. High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle.
Caraballo JM; Acosta JC; Cortés MA; Albajar M; Gómez-Casares MT; Batlle-López A; Cuadrado MA; Onaindia A; Bretones G; Llorca J; Piris MA; Colomer D; León J
Oncotarget; 2014 Jul; 5(13):4694-708. PubMed ID: 25051361
[TBL] [Abstract][Full Text] [Related]
12. Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma.
Curiel-Lewandrowski C; Yamasaki H; Si CP; Jin X; Zhang Y; Richmond J; Tuzova M; Wilson K; Sullivan B; Jones D; Ryzhenko N; Little F; Kupper TS; Center DM; Cruikshank WW
J Clin Invest; 2011 Dec; 121(12):4838-49. PubMed ID: 22080865
[TBL] [Abstract][Full Text] [Related]
13. Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical risk.
Winkler D; Schneider C; Zucknick M; Bögelein D; Schulze K; Zenz T; Mohr J; Philippen A; Huber H; Bühler A; Habermann A; Benner A; Döhner H; Stilgenbauer S; Mertens D
Haematologica; 2010 Nov; 95(11):1880-8. PubMed ID: 20713460
[TBL] [Abstract][Full Text] [Related]
14. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
17. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
18. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia.
Boonstra JG; von't Veer MB; Gratama JW
J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702
[TBL] [Abstract][Full Text] [Related]
19. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
